Pathologic complete response does not predict overall or disease-free survival in patients with rectal cancer, according to a ...

A recent meta-analysis reveals no link between pathologic complete response and long-term survival in rectal cancer, ...

A new study published in the journal of BMC Surgery showed that robotic surgery for rectal cancer exhibits oncological and ...

The surge in early-onset colorectal cancer has prompted urgent campaigns to educate the public and health care ...

Cheikh Khalifa International University Hospital in Casablanca successfully carried out its first robot-assisted ...

Recent analyses have shown that da Vinci robotic surgery achieves a 99% reliability rate, with technical issues rarely ...

Q2 2025 Earnings Call Transcript July 22, 2025 Intuitive Surgical, Inc. beats earnings expectations. Reported EPS is $2.19, ...

The Mohammed VI Foundation for Science and Health (FM6SS) achieved a milestone in robotic surgery Thursday, July 24 with the successful completion of its first robot-assisted visceral operation at ...

A new study by a Tulane University researcher casts doubt on a widely used shortcut in rectal cancer drug trials, raising concerns that some treatments may be fast-tracked for approval without ...

Concerns raised about reliability of tumor-free status as a measure for rectal cancer treatment approval.

A new study raises concerns about a widely used shortcut in approving rectal cancer drugs, showing that the absence of detectable tumors after treatment—known as pathologic complete response ...

Researchers explain that in comparison to adults born in 1950, those born in 1990 are twice as likely to develop colon cancer — and a whopping four times more likely to develop rectal cancer.